Apollo AyurVAID, India’s premier NABH-accredited network of precision Ayurveda hospitals, has expanded its footprint into the Ayurveda product segment. This strategic move marks a significant milestone for the organisation, taking its clinical expertise beyond hospital settings and into the fast-growing ₹60,000 crore Indian Ayurveda market, which is expanding at over 16% annually.
Launching a Clinically Validated Product Line
Apollo AyurVAID’s new portfolio includes classical formulations, over-the-counter (OTC) products, and medical foods, all developed to meet the increasing demand for safe, standardised, and clinically validated Ayurveda solutions. In a first for the industry, each product is certified safe by NABL-accredited laboratories, ensuring absence of heavy metals, aflatoxins, and microbial contaminants.
Every product features a QR code on the packaging allowing consumers to access individual lab test reports, reinforcing transparency and consumer trust.
Leadership Vision and Strategic Intent
Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals and Chairperson, Apollo AyurVAID, stated:
“Apollo AyurVAID’s foray into tested-safe Ayurveda products is a pivotal step in redefining traditional medicine with a commitment to safety, transparency, and efficacy. By integrating innovation with Ayurvedic wisdom, we aim to shape the future of integrative medicine in India and globally.”
Mr. Rajiv Vasudevan, Founder, MD & CEO, Apollo AyurVAID, added:
“With two decades of clinical experience, we are now entering a high-potential consumer space. This vertical complements our care model and opens new revenue streams. We aim for ₹500 crore in revenue from this segment in the next five years.”
Product Categories and Consumer Reach
Apollo AyurVAID’s new product business will operate as a dedicated unit within the organisation.
- Classical formulations will be available through prescriptions.
- OTC and medical food ranges will be distributed via retail and digital platforms including Apollo Pharmacies and Apollo 24|7.
As per the press release, the OTC range introduces innovative formats such as creams, transdermal pads, and essential extracts, targeting segments like women, children, elders, and specific needs like pain, stress, sleep, and skin health. The high medical content ensures top-tier efficacy.
Additionally, Apollo AyurVAID has partnered with Avesthagen Limited, a systems biology firm, to co-develop scientifically validated, botanical-based dietary supplements. These will carry the brand name AvestaAyurVAID and be free from sugar, artificial colours, and flavours. A specialised line of Ayurveda-based medical foods for specific clinical indications will follow.
Scaling Presence and Impact
The company is expanding its hospital network in an asset-light manner, planning nine new locations this fiscal, scaling to 350 beds, and targeting over 50,000 patients. With a 75% CAGR over the last 2–3 years, Apollo AyurVAID is set to surpass ₹100 crore annual revenue by mid-next year—an unprecedented achievement in India’s Ayurveda services sector.
Integrated Distribution and Digital Accessibility
Apollo AyurVAID will adopt a multi-tier distribution strategy to maximise reach. The products will be available via:
- Apollo AyurVAID hospitals and clinics
- Apollo Pharmacies
- Apollo 24|7
- Leading e-commerce platforms
- The official Apollo AyurVAID website
This integrated channel approach aims to make evidence-based, precision Ayurveda widely accessible.
About Apollo AyurVAID
Founded in 2005 and integrated into the Apollo Group in 2022, Apollo AyurVAID leads the way in delivering protocol-driven, evidence-based Ayurveda care across India. The hospital network provides chronic disease management, rehabilitation, and integrative treatments across neurology, oncology, nephrology, OBGYN, and metabolic disorders.
Apollo AyurVAID has centres in Bengaluru, Chennai, New Delhi, Kochi, Almora, and Hyderabad. It combines Ayurvedic principles with modern clinical protocols to support prevention, treatment, rehabilitation, and whole-person wellbeing.